Time Commitment: 3 Hrs 0 min over 56 days
Group Size: 40 Maximum Group Members
Credits Available: 3.5 AMA PRA Category 1 Credits™, 3.5 ANCC, 3.5 ACPE

This CME/CE/CPE-certified activity has been developed to bring together different members of the breast cancer care team in small-group virtual workshops that allow interactions through various collaborative educational experiences. The goal of this activity is to improve the knowledge, confidence, competence, and performance of learners in selecting individualized treatment for patients with HER2+ breast cancer. It is anticipated that a total of 8 groups, headed by a group leader, will participate in this activity.

CME/CE Accreditation Information

Self Study

Live Group Discussions

  • The Evolving Treatment Landscape and Unanswered Questions in HER2+ Breast Cancer

    This live discussion will focus on providing optimal care for patients with HER2+ breast cancer. Topics to be discussed include recent changes to the treatment landscape, unanswered questions in HER2+ breast cancer, and creating evidence-based, patient-specific plans for HER2+ breast cancer.

  • Applying Evidence to Practice: Case Studies and Action Plans

    In this discussion, we will review case study responses and how the findings apply to improving care for patients with HER2+ breast cancer; we will also review challenges, clinical controversies, and aspects of patient treatment that should be considered. Action plans will presented as we reflect on how our practice will evolve as a result of this CME activity.

Group Case Studies

  • Treatment Decisions in Early Breast Cancer: Patient Case 1 - Ms Watkins

    Meet Ms Watkins, a younger patient with ER-positive, HER2-positive breast cancer. The group objective of this segment is to explore all aspects of disease management in this patient with residual disease post neoadjuvant therapy and surgery.

  • Clinical Decision-making in Advanced Disease: Patient Case 2 - Mrs Parker

    Meet Mrs Parker, an older patient with metastatic HER2-positive breast cancer that has progressed following chemotherapy. The group objective of this segment is to explore all aspects of disease management in this patient.

My Action Plan

  • Create an Action Plan

    Reflect on the learning from this CME activity and type a few sentences as to how your practice will evolve.

Interested in becoming a Group Leader?

The group leaders for this program are among the leading experts in the management of patients with breast cancer. Apply Now

You cannot sign up as a Group Member because there are no groups available or because you are already signed up.

Completed Groups

Ilana Schlam, MD
Assistant professor of medicine - medical oncologist
Sonya Reid, MD, MPH
Assistant Professor
Manali Bhave, MD
Assistant Professor
David Page, MD
Medical Oncology
Ryan Rader, MD
Hematology/Oncology Fellow
Annette Fontaine, MD
MD, Chief Medical Officer
Jasmine Patel, PharmD
Jennie Petruney, ANP
Jaime Kaushik, PharmD
Clinical pharmacy specialist
Abigail Shockley, PharmD
Clinical Pharmacy Specialist